Debiopharm develops, manufactures and invests in innovative therapies and technologies that respond to high unmet medical needs in oncology and bacterial infections. Debiopharm Innovation Fund aims to provide strategic funding and guidance for companies with Smart Data & Digital Health solutions with the ambition to change the way drugs are developed and the way patients are treated.

Their growing portfolio of company achievements include 18 FDA clearances or CE marks and 2 IPOs along with 3 successful exits from mergers & acquisitions. Since 2018 Debiopharm has invested over USD 150 million, leading 22 of the past 30 investment rounds

Keep up to date on Frontiers Health by following us on LinkedIn, Facebook, and Twitter.